Journal of clinical ultrasound : JCU · 2026
Diagnostic Performance of Diffusion-Weighted Imaging for Evaluation of Breast Lesions: Correlation With Prognostic Factors and Histological Phenotypes.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Konukoglu Osman, Kaya Murat, Arslan Baris Can
Аннотация
PURPOSE: To investigate the role of diffusion-weighted imaging (DWI) in the differential diagnosis of breast lesions and to determine whether there is an association with histological subtypes and prognostic factors.
MATERIALS & METHODS: This retrospective study was approved by our institution's ethics committee. A total of 456 patients who underwent ultrasound-guided tru-cut biopsy between January 2024 and January 2025 were evaluated. Patients who had pre-biopsy breast MRI examinations with diagnostically adequate DWI sequences were included. Apparent diffusion coefficient values (ADCmean and ADCratio) were measured.
RESULTS: The mean age of the patients was 46.79 ± 12.55 years. A total of 96 breast masses were evaluated in the study, of which 44.79% (n = 43) were benign, and 55.21% (n = 53) were malignant. A statistically significant difference was observed between the benign group (1.22 ± 0.24 × 10-3 mm2/s) and the malignant group (0.76 ± 0.18 × 10-3 mm2/s) in terms of ADCmean values (p < 0.001). The cut-off value for the ADCmean was determined to be 0.955 × 10-3 mm2/s (p < 0.001). No statistically significant association was found among histological phenotypes within the malignant group (p > 0.05). A statistically significant difference in ADCratio values was observed between HER2-negative cases (0.56 ± 0.12) and HER2-positive cases (0.49 ± 0.14) (p = 0.043).
CONCLUSION: DWI and ADC represent reliable methods for distinguishing between benign and malignant breast lesions. The observed association between ADCratio values and HER2 expression suggests that this parameter may be useful in identifying breast cancer patients with poor prognostic profiles.
MATERIALS & METHODS: This retrospective study was approved by our institution's ethics committee. A total of 456 patients who underwent ultrasound-guided tru-cut biopsy between January 2024 and January 2025 were evaluated. Patients who had pre-biopsy breast MRI examinations with diagnostically adequate DWI sequences were included. Apparent diffusion coefficient values (ADCmean and ADCratio) were measured.
RESULTS: The mean age of the patients was 46.79 ± 12.55 years. A total of 96 breast masses were evaluated in the study, of which 44.79% (n = 43) were benign, and 55.21% (n = 53) were malignant. A statistically significant difference was observed between the benign group (1.22 ± 0.24 × 10-3 mm2/s) and the malignant group (0.76 ± 0.18 × 10-3 mm2/s) in terms of ADCmean values (p < 0.001). The cut-off value for the ADCmean was determined to be 0.955 × 10-3 mm2/s (p < 0.001). No statistically significant association was found among histological phenotypes within the malignant group (p > 0.05). A statistically significant difference in ADCratio values was observed between HER2-negative cases (0.56 ± 0.12) and HER2-positive cases (0.49 ± 0.14) (p = 0.043).
CONCLUSION: DWI and ADC represent reliable methods for distinguishing between benign and malignant breast lesions. The observed association between ADCratio values and HER2 expression suggests that this parameter may be useful in identifying breast cancer patients with poor prognostic profiles.